BIOMAT Database Logo BIOMAT Database Logo

Synthesis of 5-[alkoxy-(4-nitro-phenyl)-methyl]-uridines and study of their cytotoxic activity. 2010

Lucie Brulíková, and Petr Dzubák, and Marián Hajdúch, and Lenka Lachnitová, and Madhusudhan Kollareddy, and Milan Kolár, and Katerina Bogdanová, and Jan Hlavác
Department of Organic Chemistry, Faculty of Science, Palacký University, Tr. Svobody 8, 771 46 Olomouc, Czech Republic.

A series of uridine analogues modified at the 5-position with the 5-[alkoxy-(4-nitrophenyl)-methyl] moiety was synthesized. Nucleosides were formed as a mixture of two diastereoisomers, which were separated and tested for their cytotoxic activity in vitro against different cancer cell lines and for antimicrobial activity. Relationships between structure and the above mentioned activities were studied. The cytotoxic activity was slightly increased in some cases by transformation of bases to nucleosides. Depending on the length of the alkyl chain increased cytotoxic and antimicrobial activity were noted. The cytotoxic activity of the nucleosides was not due to cell cycle alterations, DNA and/or RNA synthesis.

UI MeSH Term Description Entries
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D001419 Bacteria One of the three domains of life (the others being Eukarya and ARCHAEA), also called Eubacteria. They are unicellular prokaryotic microorganisms which generally possess rigid cell walls, multiply by cell division, and exhibit three principal forms: round or coccal, rodlike or bacillary, and spiral or spirochetal. Bacteria can be classified by their response to OXYGEN: aerobic, anaerobic, or facultatively anaerobic; by the mode by which they obtain their energy: chemotrophy (via chemical reaction) or PHOTOTROPHY (via light reaction); for chemotrophs by their source of chemical energy: CHEMOLITHOTROPHY (from inorganic compounds) or chemoorganotrophy (from organic compounds); and by their source for CARBON; NITROGEN; etc.; HETEROTROPHY (from organic sources) or AUTOTROPHY (from CARBON DIOXIDE). They can also be classified by whether or not they stain (based on the structure of their CELL WALLS) with CRYSTAL VIOLET dye: gram-negative or gram-positive. Eubacteria
D014529 Uridine A ribonucleoside in which RIBOSE is linked to URACIL. Allo-Uridine,Allouridine,Allo Uridine
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D020128 Inhibitory Concentration 50 The concentration of a compound needed to reduce population growth of organisms, including eukaryotic cells, by 50% in vitro. Though often expressed to denote in vitro antibacterial activity, it is also used as a benchmark for cytotoxicity to eukaryotic cells in culture. IC50,Concentration 50, Inhibitory

Related Publications

Lucie Brulíková, and Petr Dzubák, and Marián Hajdúch, and Lenka Lachnitová, and Madhusudhan Kollareddy, and Milan Kolár, and Katerina Bogdanová, and Jan Hlavác
Synthesis and cytotoxic activity of various 5-[alkoxy-(4-nitro-phenyl)-methyl]-uracils in their racemic form.
December 2007, Bioorganic & medicinal chemistry letters,
Lucie Brulíková, and Petr Dzubák, and Marián Hajdúch, and Lenka Lachnitová, and Madhusudhan Kollareddy, and Milan Kolár, and Katerina Bogdanová, and Jan Hlavác
Synthesis and antifilarial activity of N-[4-[[4-alkoxy-3-[(dialkylamino)methyl]phenyl]amino]- 2-pyrimidinyl]-N'-phenylguanidines.
September 1983, Journal of medicinal chemistry,
Lucie Brulíková, and Petr Dzubák, and Marián Hajdúch, and Lenka Lachnitová, and Madhusudhan Kollareddy, and Milan Kolár, and Katerina Bogdanová, and Jan Hlavác
4-Nitro-phenyl 2-methyl-benzoate.
November 2009, Acta crystallographica. Section E, Structure reports online,
Lucie Brulíková, and Petr Dzubák, and Marián Hajdúch, and Lenka Lachnitová, and Madhusudhan Kollareddy, and Milan Kolár, and Katerina Bogdanová, and Jan Hlavác
6-Chloro-N-methyl-5-nitro-N-phenyl-pyrimidin-4-amine.
October 2011, Acta crystallographica. Section E, Structure reports online,
Lucie Brulíková, and Petr Dzubák, and Marián Hajdúch, and Lenka Lachnitová, and Madhusudhan Kollareddy, and Milan Kolár, and Katerina Bogdanová, and Jan Hlavác
2,2-Diethyl 4-methyl 5-(4-nitro-phen-yl)-4-phenyl-pyrrolidine-2,2,4-tricarboxyl-ate.
October 2011, Acta crystallographica. Section E, Structure reports online,
Lucie Brulíková, and Petr Dzubák, and Marián Hajdúch, and Lenka Lachnitová, and Madhusudhan Kollareddy, and Milan Kolár, and Katerina Bogdanová, and Jan Hlavác
4-Formyl-2-nitro-phenyl 3-nitro-2-methyl-benzoate.
January 2014, Acta crystallographica. Section E, Structure reports online,
Lucie Brulíková, and Petr Dzubák, and Marián Hajdúch, and Lenka Lachnitová, and Madhusudhan Kollareddy, and Milan Kolár, and Katerina Bogdanová, and Jan Hlavác
5-[1-(4-Methyl-phen-yl)-2-nitro-but-yl]-4-phenyl-1,2,3-selenadiazole.
March 2013, Acta crystallographica. Section E, Structure reports online,
Lucie Brulíková, and Petr Dzubák, and Marián Hajdúch, and Lenka Lachnitová, and Madhusudhan Kollareddy, and Milan Kolár, and Katerina Bogdanová, and Jan Hlavác
4-Nitro-phenyl 4-hy-droxy-3-methyl-benzoate.
December 2012, Acta crystallographica. Section E, Structure reports online,
Lucie Brulíková, and Petr Dzubák, and Marián Hajdúch, and Lenka Lachnitová, and Madhusudhan Kollareddy, and Milan Kolár, and Katerina Bogdanová, and Jan Hlavác
3-Fluoro-4-nitro-phenyl 4-methyl-benzene-sulfonate.
April 2011, Acta crystallographica. Section E, Structure reports online,
Lucie Brulíková, and Petr Dzubák, and Marián Hajdúch, and Lenka Lachnitová, and Madhusudhan Kollareddy, and Milan Kolár, and Katerina Bogdanová, and Jan Hlavác
Synthesis of 4-(4-ethyl-phenyl)-3-(4-methyl-phenyl)-1,2,4-oxadiazol-5(4H)-one and 4-(4-ethyl-phenyl)-3-(4-methyl-phenyl)-1,2,4-oxadiazole-5(4H)-thione and solvent effects on their infrared spectra in organic solvents.
April 2021, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy,
Copied contents to your clipboard!